×

Combination therapy with an anti-hyaluronan agent and therapeutic agent

  • US 9,913,822 B2
  • Filed: 03/15/2013
  • Issued: 03/13/2018
  • Est. Priority Date: 04/04/2012
  • Status: Active Grant
First Claim
Patent Images

1. A combination, comprising:

  • a) a composition comprising a soluble PEGylated PH20 hyaluronidase;

    wherein the PH20 hyaluronidase comprises an amino acid sequence that has at least 95% sequence identity to the sequence set forth in SEQ ID NO;

    4; and

    b) a composition comprising a tumor-targeted taxane that is nab-paclitaxel or nab-docetaxel.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×